Startseite
HD

Hakim Djaballah

1.2K
32
22

Ausbildung

  • Univeristy of Leicester
    Abschluss PhD
    Studienrichtung Biochemistry
    Startdatum 01/1989
    Enddatum 01/1992

Berufserfahrung

KU

Professor of Chemical Biology

Korea University of Science and Technology •

01/2014 – 01/2017 •

IP

CEO & Director

Institut Pasteur Korea •

01/2014 – 01/2016 •

MS

Director, HTS Core Facility

Memorial Sloan Kettering Cancer Center •

01/2003 – 01/2014 •

Hakim Djaballah — Founder & CEO | PharmaCountry